The saline-immersion/irrigation technique in colorectal endoscopic submucosal dissection is a safe and effective minimally ...

Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212). Panitumumab ...

EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are commonly used for the minimally invasive treatment of submucosal lesions of the gastrointestinal tract. To evaluate ...

New York, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Endoscopic Submucosal Dissection Market by Product, Indication, End ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

Endoscopic submucosal dissection (ESD) is a safe and very effective alternative to surgery for the treatment of colorectal tumors, reports a new study from Japan. Surgery has been the only available ...